{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:21:38Z","timestamp":1790724098046,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1124\/dmd.119.087940","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T15:35:14Z","timestamp":1572881714000},"page":"8-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with Obesity"],"prefix":"10.1016","volume":"48","author":[{"given":"Veronica","family":"Krogstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4169-9757","authenticated-orcid":false,"given":"Alexandra","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Robertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne K.","family":"Kringen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Carlo","family":"Angeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8ran","family":"Hjelmes\u00e6th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-7395","authenticated-orcid":false,"given":"Per","family":"Artursson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00c5sberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy B.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.119.087940_bib1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1124\/dmd.114.058834","article-title":"Expression of hepatic drug-metabolizing cytochrome P450 enzymes and their intercorrelations: a meta-analysis","volume":"42","author":"Achour","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/dmd.107.015511","article-title":"Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes","volume":"35","author":"Aitken","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.119.087940_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","article-title":"Impact of obesity on drug metabolism and elimination in adults and children","volume":"51","author":"Brill","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.119.087940_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cpt.1409","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for cytochrome P450 (CYP)2D6 genotype and atomoxetine therapy","volume":"106","author":"Brown","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/clpt.2014.159","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing","volume":"96","author":"Caudle","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clpt.2006.08.014","article-title":"Sex differences in CYP3A activity using intravenous and oral midazolam","volume":"80","author":"Chen","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/bcp.13908","article-title":"Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine","volume":"85","author":"Clermont","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.119.087940_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cpt.967","article-title":"Protein abundance of clinically relevant drug-metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens","volume":"104","author":"Drozdzik","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11695-010-0337-2","article-title":"Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese","volume":"21","author":"Edholm","year":"2011","journal-title":"Obes Surg"},{"key":"10.1124\/dmd.119.087940_bib12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/jpet.106.106013","article-title":"Intestinal and hepatic metabolic activity of five cytochrome P450 enzymes: impact on prediction of first-pass metabolism","volume":"318","author":"Galetin","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.087940_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2016.06.015","article-title":"Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes","volume":"92","author":"Gao","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.087940_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0006-2952(95)00192-3","article-title":"Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver","volume":"50","author":"George","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.087940_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bdd.2062","article-title":"Quantifying gut wall metabolism: methodology matters","volume":"38","author":"Hatley","year":"2017","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.119.087940_bib16","doi-asserted-by":"crossref","first-page":"e021878","DOI":"10.1136\/bmjopen-2018-021878","article-title":"Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)","volume":"8","author":"Hjelmes\u00e6th","year":"2018","journal-title":"BMJ Open"},{"key":"10.1124\/dmd.119.087940_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-2952(92)90010-G","article-title":"Effect of age and gender on the activity of human hepatic CYP3A","volume":"44","author":"Hunt","year":"1992","journal-title":"Biochem Pharmacol"},{"issue":"Suppl","key":"10.1124\/dmd.119.087940_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.taap.2005.01.030","article-title":"The human genome project and novel aspects of cytochrome P450 research","volume":"207","author":"Ingelman-Sundberg","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.119.087940_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mcp.2003.21","article-title":"Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking","volume":"73","author":"Kang","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.tiv.2009.12.011","article-title":"Regulation of VDR expression in rat and human intestine and liver\u2014consequences for CYP3A expression","volume":"24","author":"Khan","year":"2010","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.119.087940_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000139380","article-title":"Drug interactions and interindividual variability of ciclosporin metabolism in the small intestine","volume":"52","author":"Lampen","year":"1996","journal-title":"Pharmacology"},{"key":"10.1124\/dmd.119.087940_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00008571-200309000-00005","article-title":"Differential expression and function of CYP2C isoforms in human intestine and liver","volume":"13","author":"L\u00e4pple","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.119.087940_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.62.1.162","article-title":"Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism","volume":"62","author":"Lin","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.119.087940_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2362.2003.01154.x","article-title":"Variable expression of CYP and Pgp genes in the human small intestine","volume":"33","author":"Lindell","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/dmd.119.087940_bib25","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.soard.2019.05.019","article-title":"CYP450 activities before and after Roux-en-Y gastric bypass: correlation with their intestinal and liver content","volume":"15","author":"Lloret-Linares","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1124\/dmd.119.087940_bib26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0090-9556(25)08440-5","article-title":"Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test","volume":"22","author":"Lown","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1023\/A:1018989211864","article-title":"Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines","volume":"16","author":"Madani","year":"1999","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.087940_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1389450118666170125144557","article-title":"Cytochrome P450 structure, function and clinical significance: a review","volume":"19","author":"Manikandan","year":"2018","journal-title":"Curr Drug Targets"},{"key":"10.1124\/dmd.119.087940_bib29","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1124\/dmd.108.021501","article-title":"Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo","volume":"36","author":"Matsubara","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2133\/dmpk.DMPK-12-RG-101","article-title":"Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes","volume":"28","author":"Misaka","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.119.087940_bib31","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acs.molpharmaceut.6b00085","article-title":"Quantitative atlas of cytochrome P450, UDP-glucuronosyltransferase, and transporter proteins in jejunum of morbidly obese subjects","volume":"13","author":"Miyauchi","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.087940_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","article-title":"Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer","volume":"36","author":"Morgan","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cpt.583","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 and voriconazole therapy","volume":"102","author":"Moriyama","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib34","first-page":"347","article-title":"Metabolic characterization of the major human small intestinal cytochrome P450s","volume":"29","author":"Obach","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib36","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.087940_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/138920008783571774","article-title":"Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues","volume":"9","author":"Pavek","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.119.087940_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/dmd.114.059246","article-title":"HepaRG cells as human-relevant in vitro model to study the effects of inflammatory stimuli on cytochrome P450 isoenzymes","volume":"43","author":"Rubin","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/dmd.114.061093","article-title":"Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine","volume":"43","author":"Shah","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.087940_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpba.2014.03.018","article-title":"A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies","volume":"101","author":"Spaggiari","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.119.087940_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcp.2012.03.017","article-title":"Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation","volume":"84","author":"Thirumaran","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.087940_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/FPC.0b013e32834c6efd","article-title":"PharmGKB summary: very important pharmacogene information for CYP1A2","volume":"22","author":"Thorn","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.119.087940_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cts.12598","article-title":"Effects of common CYP1A2 genotypes and other key factors on intraindividual variation in the caffeine metabolic ratio: an exploratory analysis","volume":"12","author":"Tian","year":"2019","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.119.087940_bib45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/clpt.2012.261","article-title":"Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects","volume":"93","author":"Ulvestad","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clpt.2003.10.008","article-title":"Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens","volume":"75","author":"von Richter","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib47","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1021\/acs.molpharmaceut.7b00364","article-title":"Variability in mass spectrometry-based quantification of clinically relevant drug transporters and drug metabolizing enzymes","volume":"14","author":"Wegler","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.087940_bib48","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.1840380424","article-title":"Sex is a major determinant of CYP3A4 expression in human liver","volume":"38","author":"Wolbold","year":"2003","journal-title":"Hepatology"},{"key":"10.1124\/dmd.119.087940_bib49","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1124\/dmd.107.016436","article-title":"Expression of constitutive androstane receptor, hepatic nuclear factor 4\u03b1, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver","volume":"35","author":"Wortham","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087940_bib50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2125.2011.04076.x","article-title":"Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes","volume":"73","author":"Yang","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.119.087940_bib51","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.103341.109","article-title":"Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver","volume":"20","author":"Yang","year":"2010","journal-title":"Genome Res"},{"key":"10.1124\/dmd.119.087940_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.119.087940_bib53","doi-asserted-by":"crossref","first-page":"e0128547","DOI":"10.1371\/journal.pone.0128547","article-title":"Effect of cytochrome b5 content on the activity of polymorphic CYP1A2, 2B6, and 2E1 in human liver microsomes","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/dmd.119.087940_bib54","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1124\/dmd.116.069849","article-title":"Correlation of cytochrome P450 oxidoreductase expression with the expression of 10 isoforms of cytochrome P450 in human liver","volume":"44","author":"Zhang","year":"2016","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562408067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562408067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.087940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:53:22Z","timestamp":1740056002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562408067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S009095562408067X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.087940","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with Obesity","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.087940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}